Publications by authors named "C R Waldman"
Article Synopsis
- - This study aimed to investigate how acute myocardial infarction (AMI) affects patients with bleeding or hypercoagulable disorders, because research on this topic is limited.
- - Analyzing data from hospitalizations between 2016 to 2020, the study found that out of over 4 million AMI cases, 9.1% had these disorders, with higher in-hospital mortality rates in patients with bleeding and mixed disorders compared to those without.
- - Patients with bleeding or hypercoagulable disorders who received invasive treatment for AMI had significantly lower risks of death and other serious complications, indicating that invasive strategies improve outcomes for these patients.
Aim: The "2024 AHA/ACC/AMSSM/HRS/PACES/SCMR Guideline for the Management of Hypertrophic Cardiomyopathy" provides recommendations to guide clinicians in the management of patients with hypertrophic cardiomyopathy.
Methods: A comprehensive literature search was conducted from September 14, 2022, to November 22, 2022, encompassing studies, reviews, and other evidence on human subjects that were published in English from PubMed, EMBASE, the Cochrane Library, the Agency for Healthcare Research and Quality, and other selected databases relevant to this guideline. Additional relevant studies, published through May 23, 2023, during the guideline writing process, were also considered by the writing committee and added to the evidence tables, where appropriate.
Aim: The "2024 AHA/ACC/AMSSM/HRS/PACES/SCMR Guideline for the Management of Hypertrophic Cardiomyopathy" provides recommendations to guide clinicians in the management of patients with hypertrophic cardiomyopathy.
Methods: A comprehensive literature search was conducted from September 14, 2022, to November 22, 2022, encompassing studies, reviews, and other evidence on human subjects that were published in English from PubMed, EMBASE, the Cochrane Library, the Agency for Healthcare Research and Quality, and other selected databases relevant to this guideline. Additional relevant studies, published through May 23, 2023, during the guideline writing process, were also considered by the writing committee and added to the evidence tables, where appropriate.
Case Presentation: We describe a case of a man who developed severe caustic injury of his upper gastrointestinal tract after ingestion of a commercially available 9.5% hydrochloric acidic cleaning solution. He rapidly deteriorated and required endotracheal intubation.
View Article and Find Full Text PDFArticle Synopsis
- Focused on ten notable studies from the 2023 American Heart Association Scientific Sessions, this review summarizes advancements in cardiovascular disease research.
- Included studies evaluated various treatments and interventions, such as semaglutide for weight management in non-diabetic patients, dapagliflozin post-myocardial infarction, and the impact of sodium intake on blood pressure.
- The findings highlight innovative approaches for preventing and managing cardiovascular diseases, emphasizing novel therapies and techniques to improve patient outcomes.